EE200300321A - Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal - Google Patents

Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal

Info

Publication number
EE200300321A
EE200300321A EEP200300321A EEP200300321A EE200300321A EE 200300321 A EE200300321 A EE 200300321A EE P200300321 A EEP200300321 A EE P200300321A EE P200300321 A EEP200300321 A EE P200300321A EE 200300321 A EE200300321 A EE 200300321A
Authority
EE
Estonia
Prior art keywords
infertility treatment
maturation during
endometrial maturation
during infertility
antigenic antigens
Prior art date
Application number
EEP200300321A
Other languages
English (en)
Inventor
Hegele-Hartung Christa
Hess-Stumpp Holger
M. Beier Henning
Krusche Claudia
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300321A publication Critical patent/EE200300321A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
EEP200300321A 2001-01-09 2002-01-09 Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal EE200300321A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (1)

Publication Number Publication Date
EE200300321A true EE200300321A (et) 2003-10-15

Family

ID=27116200

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300321A EE200300321A (et) 2001-01-09 2002-01-09 Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal

Country Status (25)

Country Link
US (1) US20040152684A1 (et)
EP (1) EP1365765B1 (et)
JP (1) JP2004520411A (et)
CN (1) CN1244329C (et)
AR (1) AR032390A1 (et)
AT (1) ATE367817T1 (et)
AU (1) AU2002253488B2 (et)
BG (1) BG107977A (et)
BR (1) BR0206367A (et)
CA (1) CA2433776A1 (et)
CZ (1) CZ20031864A3 (et)
DE (1) DE60221359T2 (et)
DK (1) DK1365765T3 (et)
EE (1) EE200300321A (et)
ES (1) ES2290284T3 (et)
HK (1) HK1065953A1 (et)
HR (1) HRP20030628A2 (et)
HU (1) HUP0302632A2 (et)
IL (1) IL156729A0 (et)
MX (1) MXPA03006156A (et)
NO (1) NO20033125L (et)
NZ (1) NZ526908A (et)
PL (1) PL361689A1 (et)
SK (1) SK8612003A3 (et)
WO (1) WO2002067910A2 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
ES2716862T3 (es) * 2014-12-22 2019-06-17 Ferring Bv Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
HRP20030628A2 (en) 2005-06-30
JP2004520411A (ja) 2004-07-08
US20040152684A1 (en) 2004-08-05
NO20033125L (no) 2003-09-09
BR0206367A (pt) 2003-12-23
CN1496263A (zh) 2004-05-12
BG107977A (bg) 2004-08-31
CA2433776A1 (en) 2002-09-06
IL156729A0 (en) 2004-02-08
DE60221359D1 (de) 2007-09-06
PL361689A1 (en) 2004-10-04
NO20033125D0 (no) 2003-07-08
HUP0302632A2 (hu) 2003-11-28
ES2290284T3 (es) 2008-02-16
HK1065953A1 (en) 2005-03-11
AR032390A1 (es) 2003-11-05
DE60221359T2 (de) 2008-04-17
CN1244329C (zh) 2006-03-08
SK8612003A3 (en) 2004-03-02
WO2002067910A2 (en) 2002-09-06
CZ20031864A3 (en) 2004-03-17
DK1365765T3 (da) 2007-10-29
MXPA03006156A (es) 2003-09-16
WO2002067910A3 (en) 2003-02-06
AU2002253488B2 (en) 2007-02-15
NZ526908A (en) 2005-07-29
EP1365765A2 (en) 2003-12-03
EP1365765B1 (en) 2007-07-25
ATE367817T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
NO20031218D0 (no) Kombinasjonsterapi for behandling av autoimmunsykdommer ved anvendelse av B-celle reduserende/immunregulerende antistoff kombinasjon
IL151355A0 (en) Vaccine for the treatment of artherosclerosis
AU1167602A (en) Methods of therapy for hiv infection
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
GB0030918D0 (en) Activation of voice-controlled apparatus
EE200200547A (et) Neovaskularisatsiooni parendatud ravi
EE200300321A (et) Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal
HUP0401392A3 (en) Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
EP1359885A4 (en) NOS-HEMMER FOR THE TREATMENT OF WRINKLES
DE60203207D1 (de) Zange zur orthodontischen Behandlung
NO20032789L (no) Apparat for lipolyse for estetisk behandling
EP1416795A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES OF MITOCHONDRIA
ZA200306122B (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
GB0124124D0 (en) Methods of treatment
DE60103685D1 (de) Behandlung von Poriomania
GB0029573D0 (en) Activation of voice-controlled apparatus
EE05444B1 (et) FSH kasutamine viljatuse raviks
DE60005566D1 (de) Pyranoindole zur glaukombehandlung
EE200200410A (et) Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
AU2001261260A8 (en) Methods for accelerated desensitization of teeth
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
NO20025765D0 (no) Kombinasjonssett for behandling av malaria